Evolocumab may decrease the risk for adverse cardiovascular events in patients with and without diabetes.
Rates of approval for a PCSK9 inhibitor treatment are low overall.
Evolocumab is not associated with adverse cognitive effects even when low low-density lipoprotein cholesterol levels have been achieved.
Serum lipid profile changes were shown to occur within the first year of initiating antiretroviral therapy in children.
Researchers find statins could be a potential treatment option in COPD.
Less than half of patients prescribed PCSK9 inhibitors receive approval, and only about 30% ever receive therapy.
The FDA has approved a new pitavastatin for the treatment of primary hyperlipidemia or mixed dyslipidemia.
Lower incidence of major coronary events for patients with atherosclerotic vascular disease receiving intensive statins is linked with use of anacetrapib.
Clinical benefit of reduced low-density lipoprotein cholesterol (LDL-C) levels may depend on the corresponding reduction in apolipoprotein B (apoB)-containing lipoprotein particles.
Cardiovascular health in psoriatic arthritis improves with anti-tumor necrosis factor drug etanercept.
Findings for addition of evolocumab to standard tx in atherosclerotic cardiovascular disease
International Laboratories, LLC has issued a recall for one lot of Pravastatin Sodium Tablets 40mg due to mislabeling.
There is no significant difference in cognitive function for patients treated with evolocumab or placebo added to statin therapy.
Statin prescribing trends vary among nursing home residents with significant variation of prescribing across physicians.
Patients with psoriasis have high rates of cardiometabolic comorbidities.
Individuals with psoriasis have a greater risk for noncalcified coronary plaque burden compared with healthy individuals and patients with hyperlipidemia.
The FDA has approved Zypitamag for the treatment of patients with primary hyperlipidemia or mixed dyslipidemia.
Statin use after an adverse reaction is associated with lower incidences of cardiovascular events and death.
Direct-acting antiviral treatment for hepatitis C virus is linked to improved glycemic control in patients with type 2 diabetes.
Serum Vitamin D levels are related to cholesterol levels and other risk factors for cardiovascular disease in patients with juvenile idiopathic arthritis.
PCSK9 had a significant correlation with hemoglobin A1c, triglycerides, total cholesterol, LDL cholesterol, and apolipoprotein B in patients with type 1 diabetes.
A decreased risk in Parkinson's disease has been associated with total serum cholesterol and low-density lipoprotein cholesterol in men not on statin therapy.
In a study,patients with type 2 diabetes presented better glycemic control and had higher risk for mortality when not taking statins.
Two research groups successfully reduced cholesterol in humans to block the angiopoietin-like 3 gene.
Appointment-based models improve medication-taking behavior.
Dapagliflozin improved endothelial function in patients with type 2 diabetes.
Evacetrapib does not affect the primary efficacy end point of first occurrence of any component of a composite of death from cardiovascular causes in patients with high-risk vascular disease.
Study shows prevalence of atherosclerotic cardiovascular disease risk among adults under 50 without diabetes is low.
An American Heart Association survey found that patients felt least informed about the differences in cholesterol types and goals for cholesterol management.
No differences were seen in measures of executive function between the evolocumab and placebo groups.
The Cardiology Advisor Articles
- Continuous Furosemide Infusion Superior to Bolus Furosemide in Heart Failure
- ACC/AHA Release 2017 Quality Measures for STEMI/NSTEMI Management
- Role of Coffee Consumption in Heart Failure, Stroke Outcomes
- Atrial Fibrillation Survival Better With Cardiac Surgery, Cox-Maze IV
- Borderline Pulmonary Hypertension Commonly Found During Right Heart Catheterization
- Heart Failure Related to Methamphetamine Use: Possible New Epidemic?
- Cardiac Surgery: Restrictive vs Liberal Threshold for Red-Cell Transfusion
- High-Sensitivity Cardiac Troponin I Threshold Identifies Patients at Low Risk for MI, Death
- Hospital Readmissions Reduction Program Decreases Heart Failure Readmissions
- Canakinumab May Lower Lung Cancer Incidence in Patients With Atherosclerosis